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Prevalence and association of human papillomavirus, 
Epstein-Barr virus and Merkel Cell polyomavirus with 
neoplastic esophageal lesions in northern Iran 
 
Abstract 
Background: Studies concerning on esophageal squamous cell carcinoma (ESCC) 
etiological factors have been done for several decades, however, results reported from 
various investigations were not consistent. The present investigation aimed to explore the 
presence of 3 oncogenic viruses, human papilloma virus (HPV), Epstein-Barr virus (EBV) 
and Merkel cell polyomavirus (MCPyV) in the neoplastic and non- neoplastic esophageal 
lesions collected from Mazandaran, a high risk area of Iran. 
Methods: In total, 168 esophageal specimens (100 with ESCC confirmed diagnosis and 68 
without esophageal malignancy) were analyzed for HPV, EBV and MCPyV by Real Time 
PCR. 
Results: HPV DNA was detected in 27 out of the 100 neoplastic esophageal lesions 
(27.0%) and 28 out of the 68 samples from non-neoplastic group (41.2%). EBV DNA was 
detected in esophageal specimens of 10 out of the 100 neoplastic cases (10%) and 3 out of 
the 68 samples in non- neoplastic group (4.4%). MCPyV DNA was detected in esophageal 
specimens of 30 out of the 100 neoplastic cases (30.0%) and 24 out of the 68 samples in 
non- neoplastic group (35.3%). There was no statistically significant difference in HPV 
(p=0.066), EBV (p=0.143) and MCPyV (p=0.471) DNA positivity between neoplastic and 
non-neoplastic groups. 
Conclusions: This study showed that HPV, EBV and MCPyV can be detected in both 
neoplastic and non-neoplastic esophageal tissues and weakens the hypothesis of the 
pathogenic role of these viruses in esophageal malignant transformation. 
Keywords: Esophageal squamous cell carcinoma; Human papillomavirus; Epstein-Barr 
virus; Merkel cell polyomavirus. 
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Esophageal cancer is one of the most common causes of cancer death worldwide, 
with a very poor survival rate (1, 2). The incidence rate is high in certain parts of Asia, 
including China and northern Iran, wherein esophageal squamous cell carcinoma (ESCC) 
is predominant (3, 4). The main etiological factors for the development of ESCC have not 
been completely understood. Alcohol drinking, tobacco smoking and dietary or 
environmental factors was thought to play a role in the carcinogenesis (5, 6). In recent 
years, accumulating evidence has suggested that infection with oncogenic viruses may 
have pathogenetic significance in the development of ESCC (7, 8). Among these viruses, 
the core issue was focused on the infection of human papillomavirus (HPV), but causal 
relationship between HPV infection and risk of ESCC remained disputable (9-12). In 
addition, possible etiologic roles of other oncogenic viruses either alone or together with 
HPV in the development of ESCC are suggested (7, 8). 
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Contribution of Epstein-Barr virus (EBV) has been 
demonstrated in several epithelial malignancies, including 
nasopharyngeal carcinoma (NPC) and gastric carcinoma 
(13). The esophagus has anatomic vicinity with nasopharynx 
and stomach, and esophageal cancer has histological 
similarities to NPC (14). Recently, some investigators have 
proposed an association between EBV and ESCC, but their 
results are still controversial (15-19). Merkel cell 
polyomavirus (MCPyV), the most recently discovered 
human tumor virus has been accepted as the etiological 
factor in the majority of Merkel cell carcinoma (MCC), a 
rare and highly aggressive skin cancer (20). In spite of the 
fact that the route of MCPyV transmission has not been 
determined, MCPyV genome fragments have been 
demonstrated in the upper aerodigestive tract including 
esophagus (21, 22). If the upper aerodigestive tract is 
exposed constantly to this tumorigenic virus, it is 
conceivable that malignancy may develop in this region. 
Hence, to investigate whether these 3 oncogenic viruses 
could have a role in the etiology of ESCC, the prevalence of 
infection with aforementioned viruses were explored in the 
neoplastic and non- neoplastic esophageal lesions collected 
from Mazandaran, which is one of the highest ESCC risk 
areas in Iran. 
 
 
Methods 
Patients and Tissue Specimens: The present case control 
study included 168 formalin-fixed paraffin-embedded 
resection specimens from esophagus that were collected 
from the archives of two referral pathology centers affiliated 
to Babol University of Medical Sciences in Mazandaran, 
northern Iran. One-hundred out of 168 specimens had ESCC 
with confirmed diagnosis and 68 specimens diagnosed 
without malignant neoplasm in esophagus. The samples with 
ESCC histopathologic diagnosis were classified according to 
tumor differentiation grade (23). None of the subjects had 
received immunosuppressive therapy prior to endoscopy or 
surgery. This study was approved by the Ethics Committee 
of Babol University of Medical Sciences 
(Mubabol.REC.1394.79), and for all subjects, written 
informed consent was obtained. 
DNA Extraction: Five µm thick tissue sections were de-
waxed according to a previously described procedure (24). 
DNA was extracted from each tissue sample, using the High 
Pure PCR Template Preparation Kit (Roche Diagnostics, 
Mannheim, Germany) according to the manufacturer’s 
instructions. The quality and quantity of purified DNA was 
determined using a NanoDrop spectrophotometer (Thermo 
Scientific, Wilmington, USA). In addition, DNA integrity in 
each tissue sample was evaluated using human RNase P gene 
(RPP30) amplification based on a previously described 
procedure (25). Sterile microcentrifuge tubes containing only 
reaction mixtures were processed simultaneously with the 
tissue samples as a DNA isolation negative control. 
HPV DNA Detection and Genotyping: HPV DNA 
detection was performed using the qualitative Real Time 
PCR with L1 consensus primers (MY09 and MY11) as 
described previously (26). Viral genotyping was carried out 
in HPV-DNA positive samples using the AmpliSense HPV 
real-time fluorescence detection (FRT) kit (Central Research 
Institute of Epidemiology, Moscow, Russia) following 
instruction manual. This assay can reliably detect 15 
different genotypes of HPV, including types 16, 18, 31, 33, 
35, 39, 45, 51, 52, 56, 58, 59 as high-risk genotypes and 
types 6 and 11 as low-risk genotypes. 
EBV DNA Detection: The presence of EBV DNA 
sequences was investigated by qualitative real-time PCR 
using an ABI 7300 Real-Time PCR System (Applied 
Biosystems, Branchburg, NJ, USA) with the primer sets and 
TaqMan probe speciﬁc for the EBER gene of EBV as 
described elsewhere (27). In brief, 500 ng of extracted DNA 
was added to PCR mixture containing 12.5 µl YTA 2X 
Multiplex Real-Time PCR Smart mix (Yekta Tajhiz Azma, 
Tehran, Iran), 0.3 µM each primer and 0.2 µM dual-labeled 
probe. DNA extracted from supernatant of EBV-producing 
B-cell line (B95-8) was used as a positive control (28). Each 
real-time PCR run included reaction mixtures without DNA 
template as a negative control. Before testing the clinical 
samples, the specificity of the real-time PCR technique was 
evaluated using positive and negative control samples. 
MCPyV DNA Detection and Quantitation: Real-time PCR 
method was performed to detect and quantify the amount of 
MCPyV DNA load as the viral DNA copies per cell 
according to a previously described procedure (29). 
Preparation of real-time PCR calibration standards (plasmids 
containing cloned target sequences of MCPyV and human 
RNase P gene) was described elsewhere (30). The 
normalized value of the MCPyV DNA load was calculated 
by dividing the virus copy number by half of the RNase P 
gene copy number, because each diploid cell contains two 
copies of RNase P gene. 
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Statistical Analysis: Statistical analyses were done by arm 
and base packages of R software, version 3.2.4. Normality of 
quantitative variables was checked by Shapiro-Wilks test. 
Quantitative variables were reported using 95% credible 
interval or mean ± standard deviation (SD).  The differences 
between normal variables were compared by independent t 
test or one way analysis of variance (ANOVA). The 
differences between nonparametric variables were compared 
by Mann–Whitney U or Kruskal–Wallis tests. Regarding the 
small number of samples, Bayesian logistic regression was 
used to calculate adjusted and crude odds ratios (ORs) and 
95 % credible intervals (CI) using MCMC algorithm. A p-
value of ≤0.05 was considered to be statistically significant.  
 
 
Results 
Demographic and Baseline Characteristics: The current 
cross-sectional study investigated 168 esophageal lesions. 
According to the histopathologic diagnosis, study 
participants were divided in two groups: one-hundred 
subjects had neoplastic esophageal lesions, with ESCC 
confirmed diagnosis (male 59, female 41) (mean age, 
66.8±10.7 years; range, 38-91 years) and 68 subjects had no 
neoplasia in esophagus (male 42, female 26) (mean age, 
64.2±12.5 years; range, 42-90 years). There was no 
statistically significant difference between age (P=0.151) and 
gender (P=0.719) in neoplastic and non- neoplastic groups. 
Considering urban/rural residence, out of 100 subjects in 
neoplastic group 48 (48%) were urban and 52 (52%) were 
rural. From the 68 subjects in non-neoplastic group, 37 
(54.4%) and 31 (45.6%) lived in urban and rural areas, 
respectively. The samples with ESCC histopathologic 
diagnosis were classified according to tumor differentiation 
grade (23) and as follows: out of the 100 samples, 64 
(64.0%) were classified as not differentiated, 3 (3.0%) poorly 
differentiated, 16 (16.0%) moderately differentiated and 17 
(17.0%) well differentiated tumor samples. The non-
neoplastic esophageal samples were categorized based on 
histopathologic criteria: 9 (13.2%) samples were diagnosed 
with esophageal dysplasia, 52 (76.5%) with esophagitis and 
7 (10.3%) had normal histology. In terms of location of 
esophageal lesions, in neoplastic group the most common 
location was the middle third of esophagus with 41 (41%) 
cases, followed by the lower third and upper third with 35 
(35%) and 24 (24%) cases, respectively. Out of the 68 non-
neoplastic esophageal specimens, 34 (50%) cases were 
located at the lower third of esophagus, followed by 12 
(17.6%) cases and 9 (13.2%) cases in the upper third, and 
middle third respectively. The location of esophageal 
specimen was unknown in 13 (19.1 %) subjects in non-
neoplastic group. 
Detection of HPV and Viral Genotypes in Neoplastic and 
Non-neoplastic Lesions: Totally, HPV DNA sequences 
were detected in 55 (32.7%) out of the 168 tested samples, of 
which 15 (27.3 %) were infected with a single HPV type and 
six (10.9%) with two or more HPV types (multiple-type 
infection). Human papillomavirus genotype was not 
recognized in 34 (61.8%) positive samples (untypable). 
Specifically, HPV DNA was detected in 27 out of the 100 
neoplastic esophageal lesions (27.0%). Based on tumor 
differentiation grade, 34.4% of not differentiated, 6.3% of 
moderately differentiated and 23.5% of well differentiated 
tumors were HPV DNA positive. In addition, HPV DNA 
was detected in 28 out of the 68 samples from non-neoplastic 
group (41.2%). According to histopathologic diagnosis, 
33.3% of esophageal dysplasia, 46.2% of esophagitis, and 
14.3% of samples with normal histology were HPV DNA 
positive. There was no statistically significant difference in 
HPV DNA positivity between neoplastic and non-neoplastic 
groups (P=0.066). Among the neoplastic esophageal lesions, 
25.9% (7.27) harbored high risk types (HPV35, HPV39 and 
HPV45 were the most common high-risk types in neoplastic 
group, which were detected in 3 cases each), 18.5% (5.27) 
harbored low risk types and 62.9% (17.27) were untypable. 
In non-neoplastic group 21.4% (6.28) harbored high risk 
types (HPV56 was the most common high-risk type in non-
neoplastic group, which was detected in 2 cases), 17.8% 
(5.28) harbored low risk types and 60.7% (17.28) were 
untypable. Multiple-type infection was seen in 22.2% (6.27) 
of neoplastic esophageal lesions, but in none of the 28 
samples from non- neoplastic group (table 1). Regarding the 
location of esophageal lesions in neoplastic group, 20.8% 
(5.24) of the upper third, 36.6% (15.41) of the middle third, 
and 20.0% (7.35) of the lower third specimens were HPV 
DNA positive. In non-neoplastic esophageal lesions, 8.3% 
(1.12) of upper third, 55.6% (5.9) of the middle third, 61.8% 
(21.34) of the lower third, and 7.7% (1.13) of the unknown 
third specimens were HPV DNA positive. 
Detection of EBV in Neoplastic and Non-neoplastic 
Lesions: Of the 168 tested samples, EBV DNA sequence 
was found in 13 (7.7%). EBV DNA was detected in 
esophageal specimens of 10 out of the 100 (10%) neoplastic 
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cases and 3 out of the 68 samples in non- neoplastic group 
(4.4%). There was no statistically significant difference in 
EBV DNA positivity between neoplastic and non-neoplastic 
groups (P=0.143). In detail, EBV DNA was detected 
in12.5% (8.64) of not differentiated, and 11.8% (2.17) of 
well differentiated, but in none of the poorly differentiated 
and moderately differentiated tumors. In non- neoplastic 
group, only 5.8% (3.52) of esophagitis specimens contained 
EBV DNA sequence and EBV infection was not found in 
samples with esophageal dysplasia and normal histology. 
Based on the location of esophageal lesions in neoplastic 
group, 8.3% (2.24) of the upper third, 7.3% (3.41) of the 
middle third, and 14.3% (5.35) of the lower third specimens 
were EBV DNA positive. In non-neoplastic esophageal 
lesions, 5.9% (2.34) of the lower third, and 7.7% (1.13) of 
the unknown third specimens were EBV DNA positive. 
Table 1. Frequency of HPV infection in patients with neoplastic and non-neoplastic esophageal lesions 
 Study group 
OR (95% CI)* P value 
Neoplastic Esophageal  
Lesions (n=100) 
Non-Neoplastic Esophageal 
Lesions (n=68) 
Number HPV positive(% of 
all) 
27 (27.0%) 28 (41.2%) 0.53 (0.261,1.072)    0.066 
Number positive for HPV 
high-risk types(% of HPV 
positive) 
7.27 (25.9%) 6.28 (21.4 %) 0.777 (0.249,2425)    0.771 
Number positive for HPV 
low-risk types(% of HPV 
positive) 
5.27 (18.5 %) 5.28 (17.8 %) 0.665 (0.146,3.016)    0.528 
Single-type infection(% of 
HPV positive) 
4.27 (14.8%) 11.28 (39.3%) 0.218 (0.048,0.779)    0.011 
Multiple-type infection(% of 
HPV positive) 
6/27 (22.2 %) 0 (0%) - 
 
0.082 
Untypable(% of HPV 
positive) 
17.27 (62.9%) 17.28 (60.7%) 0.616 (0.269,1.411) 0.242 
*Crude odds ratio 
Detection and Quantitation of MCPyV in Neoplastic and 
Non-neoplastic Lesions: In the present study, neoplastic and 
non-neoplastic esophageal specimens were examined for the 
presence of MCPyV sequence by quantitative real-time PCR. 
Out of the 168 tested samples, the MCPyV DNA sequence 
was found in 54 (32.1%). MCPyV DNA was detected in 
esophageal specimens of 30 out of the 100 neoplastic cases 
(30.0%) and 24 out of the 68 samples in non- neoplastic 
group (35.3%). There was no statistically significant 
difference in MCPyV DNA positivity between neoplastic 
and non-neoplastic groups (P=0.471). Regarding the grade of 
tumor in neoplastic group, MCPyV infection was detected in 
31.3% (20/64) of not differentiated, 33.3% (1.3) of poorly 
differentiated, 18.8% (3.16) of moderately differentiated, and 
35.3% (6.17) of well differentiated tumors. In non-neoplastic 
group, 55.6% (5.9) of esophageal dysplasia, and 36.5% 
(19.52) of esophagitis specimens contained MCPyV DNA 
sequence. Merkel cell polyomavirus DNA sequence was not 
found in samples with normal histology. According to the 
location of esophageal lesions in neoplastic group, 29.2% 
(7.24) of the upper third, 24.4% (10.41) of the middle third, 
and 37.1% (13.35) of the lower third specimens were 
MCPyV DNA positive. In non-neoplastic esophageal 
lesions, 41.7% (5.12) of the upper third, 22.2% (2/9) of the 
middle third, 35.3% (12/34) of lower third, and 38.5% (5.13) 
of the unknown third specimens were MCPyV DNA 
positive.  
The mean MCPyV DNA load was 5.4×10
-6
±13.2×10
-6
 
and 5.6×10
-
 ±17.8×10
-6
 per cell in neoplastic cases and non-
neoplastic samples, respectively. 
There was no statistically significant difference between 
neoplastic cases and non-neoplastic samples regarding mean 
MCPyV DNA load (p=0.397). Additionally, the mean 
MCPyV copy number was higher in poorly differentiated 
(27.3×10
-6
±47.3×10
-6
) and well differentiated (15.5×10
-
6
±35.8×10
-6
) tumors compared to other histopathologic 
groups however, this difference was not statistically 
significant (p=0.245) (fig. 1). 
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Figure 1. The mean MCPyV DNA load according to 
histopathologic diagnosis in patients with neoplastic and non-
neoplastic esophageal lesions. The p-value was determined by 
the KruskalWallis test 
 
Concomitant Viral Infections in Neoplastic and Non-
neoplastic Lesions: In total, concomitant double and triple 
infection with HPV, EBV and MCPyV was seen in 
16(16.0%) neoplastic cases and 17(25.0%) non-neoplastic 
esophageal samples. No statistically significant difference 
was found between neoplastic and non-neoplastic samples 
regarding concomitant double and triple viral infection (table 2). 
Association between Viral Infections and ESCC 
Development: According to Bayesian logistic regression 
analysis, a significant inverse association between HPV 
infection and odds of ESCC was observed (OR, 0.36; 95 % 
CI: 0.17-0.77). Although EBV infection was related to 
higher risk of ESCC, it did not get the significant level (OR, 
3.21; 95 % CI: 0.75-13.57).  
Furthermore, MCPyV infection was also inversely 
associated with odds of ESCC, though the association did 
not reach a significant level (OR, 0.97; 95 % CI: 0.46-2.08). 
Adjustment for age, gender and infection with 
aforementioned viruses in Bayesian logistic regression 
model increased odds of ESCC in the middle third of 
esophagus (OR, 3.01; 95 % CI: 1.08-8.33) (table 3). 
 
Table 2. Frequency of concomitant double and triple infection with HPV, EBV and MCPyV in patients with neoplastic and 
non-neoplastic esophageal lesions 
 
 Study group 
OR (95% CI)* 
P-value 
Neoplastic 
Esophageal Lesions 
(n=100) 
Non-Neoplastic 
Esophageal Lesions 
(n=68) 
Total 
(n=168) 
HPV and EBV positive (%) 2 (2%) 2 (2.9%) 4 (2.4%) 0.675 (0.048,9.528)  1 
HPV and MCPyV positive 
(%) 
11 (11%) 11 (16.2%) 22 (13.1%) 0.642 (0.235,1.753) 0.358 
EBV and MCPyV positive 
(%) 
3 (3%) 2 (2.9%) 5 (3%) 1.02 (0.114,12.533)   1 
HPV and EBV and MCPyV 
positive (%) 
0 (0%) 2 (2.9%) 2 (1.2%) - 0.056 
*Crude odds ratio 
 
Table 3. Bayesian logistic regression analysis of the association between location of esophageal specimen, HPV, EBV and 
MCPyV infection and ESCC 
Parameter Odds Ratio (OR) of ESCC 
£ 
(95% CI)** P-value 
HPV infection 0.36 (0.17-0.77) 0.007 
EBV infection 3.21 (0.75-13.57) 0.111 
MCPyV infection 0.97 (0.46-2.08) 0.959 
Location of esophageal specimen* 
Middle third 
Lower third 
 
3.01 (1.08-8.33) 
 
0.032 
0.64 (0.27-1.49) 0.299 
* Upper third of the esophagus is taken as a reference category     ** The results were adjusted by age, gender and MCPyV DNA load 
£ ESCC: Esophageal squamous cell carcinoma 
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Discussion 
Incidence rates, histological subtypes, and etiological 
factors for esophageal cancer differ considerably between 
Asian and Western countries (1). Northern Iran, with 
markedly high ESCC incidence rate is located in the so-
called “Asian esophageal cancer belt”(3). Reasons for high 
ESCC occurrence in this region are still unclear. Infection 
with oncogenic viruses as a contributor to ESCC has been 
hypothesized by several investigators (7, 8). HPV, EBV and 
MCPyV are well known oncogenic viruses associated with 
the development of different malignancies. To investigate 
whether these 3 oncogenic viruses could have a role in the 
etiology of ESCC in northern Iran, a cross-sectional study 
was designed and a total of 168 neoplastic and non-
neoplastic esophageal specimens were examined for HPV, 
EBV and MCPyV infections. 
 In the present study, both neoplastic and non-neoplastic 
esophageal specimens were found to harbor HPV DNA. 
However, HPV infection in non-neoplastic lesions (41.2%) 
was considerably higher than ESCC cases (27.0%). The 
higher rate of HPV infection in our non-neoplastic group 
might be explained by histopathologic distribution of 
samples (76.5% of non-neoplastic samples were diagnosed 
with esophagitis and only 10.3% had normal histology). 
HPV infection was frequently detected in esophagitis 
samples by other investigators (31, 32).  
Genotype characterization for HPV revealed 12 different 
types, including 10 high-risk types and 2 low-risk types. 
HPV35, HPV39 and HPV45 were the most common high-
risk types in neoplastic group, while HPV56 was most 
prevalent high-risk type in non-neoplastic samples. Infection 
with HPV18 was not found in both neoplastic and non-
neoplastic samples; only 1 ESCC specimen with HPV16 
genotype was recognized. The results of HPV genotyping in 
the current study are in contrast with a number of reports, 
which identified HPV16 and HPV18 as the two most 
common HPV high-risk types in ESCC (32-34).  
In the present study, HPV infections caused by unknown 
or untypable genotypes were found in high rates in both 
neoplastic (62.9%) and non-neoplastic (60.7%) groups, 
which might be explained by a broad spectrum of different 
HPV genotypes that was not identified by our HPV 
genotyping kit. These data are consistent with a number of 
reports, which identified diverse and putative new HPV 
genotypes in cancerous and non-cancerous esophageal 
specimens (31, 35, 36). 
In the current investigation, EBV DNA was found in 
10% of neoplastic and 4.4% of non-neoplastic esophageal 
specimens and EBV infection was not found in samples with 
normal histology. Although EBV infection was related to 
higher risk of ESCC, but the result was not statistically 
significant. It has been demonstrated that, there is a higher 
rate of EBV- associated ESCC in Asian countries than in 
Western countries (7, 19, 37, 38).  
The different results of EBV-associated ESCC from the 
different regions could be affected by the racial and 
geographical variables (16, 39, 40). In good concordance 
with our previous report, a low copy number of MCPyV 
DNA was detected in both neoplastic and non-neoplastic 
esophageal specimens (41). The difference between MCPyV 
DNA loads (as a copy per cell) in neoplastic and non-
neoplastic groups was not statistically significant. Low copy 
numbers of MCPyV genome in both cancerous and non-
cancerous esophageal tissues might be explained by simple 
persistent viral replication in esophagus as a passenger virus 
or viral shedding from another organ (e.g. respiratory tract) 
to esophagus without any pathological outcome. Generally, 
if MCPyV-prompted tumor in humans arose as a monoclonal 
expansion of a virally transformed cell (e.g., MCC tumors); 
more than one DNA copy per tumor cell would be present 
(20). In comparison with previous publications in our region, 
present investigation was done in a larger variety of 
neoplastic and non-neoplastic esophageal specimens and to 
our knowledge, this is first study in the EMRO region to 
investigate the role of these three oncogenic viruses (HPV, 
EBV& MCPyV) in ESCC using highly sensitive real-time 
PCR technique. The results of the current investigation 
should be interpreted cautiously, due to some limitations 
including, the small percentage of samples with normal 
histology as a control and lack of fresh biopsy specimens for 
analysis. Assessment of fresh biopsy specimens by 
quantitative real-time PCR technique may shed more light on 
the role of aforementioned oncogenic viruses in the 
development of esophageal cancer.  
In conclusion, the present study showed that HPV, EBV 
and MCPyV can be detected in both neoplastic and non-
neoplastic esophageal tissues. The findings of the current 
study weaken the hypothesis of the pathogenic role of 
aforementioned oncogenic viruses in esophageal malignant 
transformation. Yet, to ascertain our results, more world-wide 
epidemiological studies with larger sample size and 
preferably on fresh biopsy specimens should be done.  
 Caspian J Intern Med 2018; 9(4):353-360  
HPV, EBV and Merkel cell polomavirus in Neoplastic Esophageal Lesions       359 
Acknowledgments 
We would like to express our appreciation to the Director 
and the staff of Cellular and Molecular Biology Research 
Center of Babol University of Medical Sciences for their 
collaboration and technical support. 
 
 
Funding: This study was financially supported by a grant 
from Babol University of Medical Sciences (Project code: 
944019). 
Conflict of Interest: The authors declare that they have no 
conflict of interest. 
 
 
References 
1.Torre LA, Bray F, Siegel RL, et al. Global cancer 
statistics, 2012. CA Cancer J Clin 2015; 65: 87-108. 
2.Di Pardo BJ, Bronson NW, Diggs BS, et al. The global 
burden of esophageal cancer: a disability-adjusted life-
year approach. World J Surg 2016; 40: 395-401. 
3.Mahboubi E, Kmet J, Cook PJ, et al. Oesophageal cancer 
studies in the Caspian Littoral of Iran: the Caspian cancer 
registry. Br J Cancer 1973; 28: 197-214. 
4.Islami F, Kamangar F, Nasrollahzadeh D, et al. 
Oesophageal cancer in Golestan Province, a high-
incidence area in northern Iran-a review. Eur J Cancer 
2009; 45: 3156-65. 
5.Wang JM, Xu B, Rao JY, et al. Diet habits, alcohol 
drinking, tobacco smoking, green tea drinking, and the 
risk of esophageal squamous cell carcinoma in the 
Chinese population. Eur J Gastroenterol Hepatol 2007; 
19: 171-6. 
6.Zheng S, Vuitton L, Sheyhidin I, et al. Northwestern 
China: a place to learn more on oesophageal cancer. Part 
one: behavioural and environmental risk factors. Eur J 
Gastroenterol Hepatol 2010; 22: 917-25. 
7.Al-Haddad S, El-Zimaity H, Hafezi-Bakhtiari S, et al. 
Infection and esophageal cancer. Ann N Y Acad Sci 
2014; 1325: 187-96. 
8.Xu W, Liu Z, Bao Q, Qian Z. Viruses, other pathogenic 
microorganisms and esophageal cancer. Gastrointest 
Tumors 2015; 2: 2-13. 
9.Cao F, Han H, Zhang F, et al. HPV infection in esophageal 
squamous cell carcinoma and its relationship to the 
prognosis of patients in northern China. Sci World J 
2014; 2014: 804738. 
10.He Z, Xu Z, Hang D, et al. Anti-HPV-E7 seropositivity 
and risk of esophageal squamous cell carcinoma in a 
high-risk population in China. Carcinogenesis  2014; 35: 
816-21. 
11.Sitas F, Egger S, Urban MI, et al. InterSCOPE study: 
Associations between esophageal squamous cell 
carcinoma and human papillomavirus serological 
markers. J Natl Cancer Inst 2012; 104: 147-58. 
12. Halec G, Schmitt M, Egger S, et al. Mucosal alpha-
papillomaviruses are not associated with esophageal 
squamous cell carcinomas: Lack of mechanistic evidence 
from South Africa, China and Iran and from a world-
wide meta-analysis. Int J Cancer 2016; 139: 85-98. 
13.Thompson MP, Kurzrock R. Epstein-Barr virus and 
cancer. Clinical Cancer Res 2004; 10: 803-21. 
14.Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. 
Squamous cell carcinoma-similarities and differences 
among anatomical sites. Am J Cancer Res 2011; 1: 275-
300. 
15.Yanai H, Hirano A, Matsusaki K, et al. Epstein-Barr virus 
association is rare in esophageal squamous cell 
carcinoma. Int J Gastrointest Cancer 2003; 33: 165-70. 
16.Wang LS, Chow KC, Wu YC, Li WY, Huang MH. 
Detection of epstein-barr virus in esophageal squamous 
cell carcinoma in Taiwan. The Am J Gastroenterol 1999; 
94: 2834-9. 
17.Jenkins TD, Nakagawa H, Rustgi AK. The association of 
Epstein-Barr virus DNA with esophageal squamous cell 
carcinoma. Oncogene 1996; 13: 1809-13. 
18.Awerkiew S, Bollschweiler E, Metzger R, et al. 
Esophageal cancer in Germany is associated with 
Epstein-Barr-virus but not with papillomaviruses. Med 
Microbiol Immunol 2003; 192: 137-40. 
19.Wu MY, Wu XY, Zhuang CX. Detection of HSV and 
EBV in esophageal carcinomas from a high-incidence 
area in Shantou China. Dis Esophagus 2005; 18: 46-50. 
20.Feng H, Shuda M, Chang Y, Moore PS. Clonal 
integration of a polyomavirus in human Merkel cell 
carcinoma. Science 2008; 319: 1096-100. 
21.Loyo M, Guerrero-Preston R, Brait M, et al. Quantitative 
detection of Merkel cell virus in human tissues and 
possible mode of transmission. Int J Cancer 2010; 126: 
2991-6. 
22.Kantola K, Sadeghi M, Lahtinen A, et al. Merkel cell 
polyomavirus DNA in tumor-free tonsillar tissues and 
upper respiratory tract samples: implications for 
 Caspian J Intern Med 2018; 9(4):353-360  
360            Yahyapour Y, et al. 
respiratory transmission and latency. J Clin Virol 2009; 
45: 292-5. 
23.Gabbert HE, Shimoda T, Hainaut P, et al. Squamous cell 
carcinoma of the esoghagus. 3rd ed. In: Hamilton SR, 
Aaltonen LA, eds. Pathology and genetics of the 
digestive system: World Health Organization 
Classification. Lyon: IARC press 2000; pp: 11-9.  
24.Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al. 
Evaluation of human papilloma virus infection in patients 
with esophageal squamous cell carcinoma from the 
Caspian Sea area, north of Iran. Asian Pac J Cancer Prev 
2012; 13: 1261-6. 
25.Sadeghi F, Salehi-Vaziri M, Ghodsi SM, et al. Prevalence 
of JC polyomavirus large T antigen sequences among 
Iranian patients with central nervous system tumors. 
Arch Virol 2015; 160: 61-8. 
26.Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al. 
High-risk and low-risk human papillomavirus in 
esophageal squamous cell carcinoma at Mazandaran, 
Northern Iran. Pathology Oncol Res 2013; 19: 385-91. 
27.Ling PD, Vilchez RA, Keitel WA, et al. Epstein-Barr 
virus DNA loads in adult human immunodeficiency virus 
type 1-infected patients receiving highly active 
antiretroviral therapy. Clin Infect Dis 2003; 37: 1244-9. 
28.Skare J, Edson C, Farley J, Strominger JL. The B95-8 
isolate of Epstein-Barr virus arose from an isolate with a 
standard genome. J Virology 1982; 44: 1088-91. 
29.Sadeghi F, Salehi-Vaziri M, Alizadeh A, et al. Detection 
of Merkel cell polyomavirus large T-antigen sequences in 
human central nervous system tumors. J Med Virol 2015; 
87: 1241-7. 
30.Salehi-Vaziri M, Sadeghi F, Alamsi-Hashiani A, et al. 
Merkel cell polyomavirus and human papillomavirus 
infections in cervical disease in Iranian women. Arch 
Virol 2015; 160: 1181-7. 
31.Tornesello ML, Monaco R, Nappi O, Buonaguro L, 
Buonaguro FM. Detection of mucosal and cutaneous 
human papillomaviruses in oesophagitis, squamous cell 
carcinoma and adenocarcinoma of the oesophagus. J Clin 
Virol 2009; 45: 28-33. 
32.Li X, Gao C, Yang Y, et al. Systematic review with meta-
analysis: the association between human papillomavirus 
infection and oesophageal cancer. Aliment Pharmacol 
Ther 2014; 39: 270-81. 
33.Hardefeldt HA, Cox MR, Eslick GD. Association 
between human papillomavirus (HPV) and oesophageal 
squamous cell carcinoma: a meta-analysis. Epidemiol 
Infect 2014; 142: 1119-37. 
34.Yong F, Xudong N, Lijie T. Human papillomavirus types 
16 and 18 in esophagus squamous cell carcinoma: a 
meta-analysis. Ann Epidemiol 2013; 23: 726-34. 
35.Togawa K, Rustgi AK. A novel human papillomavirus 
sequence based on L1 general primers. Virus Res 1995; 
36: 293-7. 
36.Lavergne D, de Villiers EM. Papillomavirus in 
esophageal papillomas and carcinomas. Int J Cancer 
1999; 80: 681-4. 
37.Terada T. Epstein-Barr virus associated lymphoepithelial 
carcinoma of the esophagus. Int J Clin Exp Med 2013; 6: 
219-26. 
38.Zhang DH, Zhang QY, Hong CQ, et al. Prevalence and 
association of human papillomavirus 16, Epstein-Barr 
virus, herpes simplex virus-1 and cytomegalovirus 
infection with human esophageal carcinoma: a case-
control study. Oncol Rep 2011; 25: 1731-8. 
39.Desgranges C, Wolf H, De-The G, et al. Nasopharyngeal 
carcinoma. X. Presence of epstein-barr genomes in 
separated epithelial cells of tumours in patients from 
Singapore, Tunisia and Kenya. Int J Cancer 1975; 16: 7-
15. 
40.Ho HC, Ng MH, Kwan HC. Factors affecting serum IgA 
antibody to Epstein-Barr viral capsid antigens in 
nasopharyngeal carcinoma. Br J Cancer 1978; 37: 356-
62. 
41.Yahyapour Y, Sadeghi F, Alizadeh A, Rajabnia R, Siadati 
S. Detection of merkel cell polyomavirus and human 
papillomavirus in esophageal squamous cell carcinomas 
and non-cancerous esophageal samples in Northern Iran. 
Pathol Oncol Res 2016; 22: 667-72. 
 
 
